Jointown Pharmaceutical Group Co Ltd600998
▲ PositiveCapitalrelevance
Plans preferred share issue to raise up to 2.8 billion yuan for debt repayment and working capital.

Jointown Pharmaceutical announced a preliminary plan for a 2026 private placement of preferred shares. The company intends to issue no more than 28 million preferred shares, raising total proceeds of up to 2.8 billion yuan. After deducting issuance expenses, the funds will be used to repay bank loans and other interest-bearing liabilities, as well as to supplement working capital. The placement will target no more than 200 qualified investors, with no preferential allotment to existing shareholders.
Jointown Pharmaceutical Group Co LtdPlans preferred share issue to raise up to 2.8 billion yuan for debt repayment and working capital.